Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 4,117-4,128 of 4,306
Drug study icon
Recruitment unclearEUCTR 2020-002787-32

Antidepressant for the prevention of DEPression following first episode Psychosis trial

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study includes Schizophrenia among several conditions.

Depression, SchizophreniaDrugA study involving a medication or substance.
Countries
United Kingdom
Sponsor
University of Birmingham
Condition
Depression, Schizophrenia
Behavioral study icon
Not recruitingISRCTN72019945

REACT study: Supporting relatives of people with psychosis or Bipolarity

This study is looking at whether questionnaires and follow-up can help people with psychosis or bipolarity. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.

In United Kingdom
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaOther
Countries
United Kingdom
Sponsor
Lancaster University
Condition
Bipolarity, Schizophrenia
Behavioral study icon
Not recruitingISRCTN60855021

Social Anxiety Research Clinic: an exploratory controlled study of standard versus enhanced cognitive behavioural therapy for social anxiety in early psychosis

This study is not recruiting in the United Kingdom. It focuses on anxiety.

In United Kingdom
Why is this study shown?

This study includes Schizophrenia among several conditions.

Anxiety, SchizophreniaOther
Countries
United Kingdom
Sponsor
Norfolk and Waveney Mental Health NHS Foundation Trust (UK)
Condition
Anxiety, Schizophrenia
Behavioral study icon
Not recruitingISRCTN60216932

The feasibility of cognitive behavioural therapy for depression and anxiety adapted for psychosis risk in primary care

This study is looking at whether cognitive behavioural therapy can help people with Psychosis or Mental and Behavioural Disorders. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.

In United Kingdom
Why is this study shown?

This study includes Schizophrenia among several conditions.

Depression, Schizophrenia, ...Other
Countries
United Kingdom
Sponsor
University of Southampton
Condition
Depression, Schizophrenia, ...
Drug study icon
CompletedEUCTR 2009-010276-16

A Long-Term, Open-Label, Safety Study of Oral Olanzapine in Adolescents with Bipolarity type I (Manic or Mixed Episodes) or Schizophrenia

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrug
Countries
Germany
Sponsor
Eli Lilly
Condition
Bipolarity, Schizophrenia
Drug study icon
CompletedEUCTR 2014-001211-39

A Phase 2, Efficacy, Safety, and Tolerability Study of ALKS 3831 in Schizophrenia with Alcohol Use Disorder

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Bulgaria
Why is this study shown?

This study includes Schizophrenia among several conditions.

Addiction, SchizophreniaDrug
Countries
Bulgaria, Poland
Sponsor
Alkermes, Inc.
Condition
Addiction, Schizophrenia
Drug study icon
CompletedEUCTR 2017-000918-36

A Phase 3 Study to Assess the Long Term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 in Subjects with Schizophrenia, Schizophreniform Disorder, or Bipolarity type I

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Austria
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrug
Countries
Austria, Bulgaria, Ireland, ...
Sponsor
Alkermes Inc
Condition
Bipolarity, Schizophrenia
Behavioral study icon
TerminatedNCT00637494

Mifepristone for depression

This study was terminated in the United States. It is testing mifepristone for depression.

Multiple locations, including Little Rock
Why is this study shown?

This study includes Schizophrenia among several conditions.

Depression, SchizophreniaBehavioralOver 22 Years
Countries
United States
Sponsor
Corcept Therapeutics
Condition
Depression, Schizophrenia
Behavioral study icon
CompletedNCT03114917

Cognitive AppRoaches to coMbatting Suicide prevention

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Ashton-under-Lyne
Why is this study shown?

This study includes Schizophrenia among several conditions.

Suicidality, SchizophreniaBehavioralOver 18 Years
Countries
United Kingdom
Sponsor
University of Manchester
Condition
Suicidality, Schizophrenia
Drug study icon
CompletedEUCTR 2014-000456-29

EFFICACY AND SAFETY OF INHALED LOXAPINE COMPARED WITH IM ANTIPSYCHOTIC IN ACUTELY AGITATED PATIENTS WITH SCHIZOPHRENIA OR Bipolarity

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Czech Republic
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrug
Countries
Czechia, Germany, Spain
Sponsor
Ferrer Internacional, S.A.
Condition
Bipolarity, Schizophrenia
Drug study icon
CompletedEUCTR 2007-005716-64

Elevated elimination rates of quetiapine in adolescent patients with schizophrenia (ICD 10: F 20.-), Bipolarity (ICD 10: F 31.-), disorders in impulse control with current PTSD (ICD...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Austria
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, PTSD, ...Drug
Countries
Austria
Sponsor
Universitätsklinik für Psychiatrie des Kindes- und Jugendalters, AKH Wien, Medizinische Universität
Condition
Bipolarity, PTSD, ...
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.